{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:33:59Z","timestamp":1785522839145,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05648-z","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:13:29Z","timestamp":1785039209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction of a risk model based on folate metabolism-related genes to predict prognosis and immunological characteristics of stomach adenocarcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Liu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenbao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"5648_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","volume":"23","author":"JA Ajani","year":"2025","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Gastric cancer, version 2.2025, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN. 2025;23:169\u201391.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"5648_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2022.0182","author":"GZ Li","year":"2022","unstructured":"Li GZ, Doherty GM, Wang J. Surgical management of gastric cancer: a review. JAMA Surg. 2022. https:\/\/doi.org\/10.1001\/jamasurg.2022.0182.","journal-title":"JAMA Surg"},{"key":"5648_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"5648_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.004","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.004.","journal-title":"Ann Oncol"},{"key":"5648_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01654-2","author":"Y Duan","year":"2025","unstructured":"Duan Y, Xu Y, Dou Y, et al. Helicobacter pylori and gastric cancer: mechanisms and new perspectives. J Hematol Oncol. 2025. https:\/\/doi.org\/10.1186\/s13045-024-01654-2.","journal-title":"J Hematol Oncol"},{"key":"5648_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126548","author":"H Waldum","year":"2021","unstructured":"Waldum H, Fossmark R. Gastritis, gastric polyps and gastric cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22126548.","journal-title":"Int J Mol Sci"},{"key":"5648_CR7","doi-asserted-by":"publisher","DOI":"10.7150\/jca.95311","author":"Y Huang","year":"2024","unstructured":"Huang Y, Shao Y, Yu X, et al. Global progress and future prospects of early gastric cancer screening. J Cancer. 2024. https:\/\/doi.org\/10.7150\/jca.95311.","journal-title":"J Cancer"},{"key":"5648_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1790936","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H, et al. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol. 2026. https:\/\/doi.org\/10.3389\/fimmu.2026.1790936.","journal-title":"Front Immunol"},{"key":"5648_CR9","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21657","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21657.","journal-title":"CA Cancer J Clin"},{"key":"5648_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04161-3","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Kawazoe A, Ya\u00f1ez P, et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-021-04161-3.","journal-title":"Nature"},{"key":"5648_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16183163","author":"M Mazurek","year":"2024","unstructured":"Mazurek M, Szewc M, Sitarz MZ, et al. Gastric cancer: an up-to-date review with new insights into early-onset gastric cancer. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16183163.","journal-title":"Cancers (Basel)"},{"key":"5648_CR12","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-166","author":"I Gullo","year":"2020","unstructured":"Gullo I, Grillo F, Mastracci L, et al. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica. 2020. https:\/\/doi.org\/10.32074\/1591-951X-166.","journal-title":"Pathologica"},{"key":"5648_CR13","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2026.26.e12","author":"JS Lee","year":"2026","unstructured":"Lee JS. Evolving molecular subtypes of gastric cancer: from past classifications to present consensus and future directions for precision therapy. J Gastric Cancer. 2026. https:\/\/doi.org\/10.5230\/jgc.2026.26.e12.","journal-title":"J Gastric Cancer"},{"key":"5648_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.12.006","author":"C Yang","year":"2021","unstructured":"Yang C, Zhang J, Liao M, et al. Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy. Drug Discov Today. 2021. https:\/\/doi.org\/10.1016\/j.drudis.2020.12.006.","journal-title":"Drug Discov Today"},{"key":"5648_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3926","author":"S Dang","year":"2024","unstructured":"Dang S, Jain A, Dhanda G, et al. One carbon metabolism and its implication in health and immune functions. Cell Biochem Funct. 2024. https:\/\/doi.org\/10.1002\/cbf.3926.","journal-title":"Cell Biochem Funct"},{"key":"5648_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105457","author":"B Petrova","year":"2023","unstructured":"Petrova B, Maynard AG, Wang P, et al. Regulatory mechanisms of one-carbon metabolism enzymes. J Biol Chem. 2023. https:\/\/doi.org\/10.1016\/j.jbc.2023.105457.","journal-title":"J Biol Chem"},{"key":"5648_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.009","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009.","journal-title":"Cell Metab"},{"key":"5648_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179339","author":"AF Sobral","year":"2024","unstructured":"Sobral AF, Cunha A, Silva V, et al. Unveiling the therapeutic potential of folate-dependent one-carbon metabolism in cancer and neurodegeneration. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25179339.","journal-title":"Int J Mol Sci"},{"key":"5648_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00739-8","author":"Y Lee","year":"2024","unstructured":"Lee Y, Vousden KH, Hennequart M. Cycling back to folate metabolism in cancer. Nat Cancer. 2024. https:\/\/doi.org\/10.1038\/s43018-024-00739-8.","journal-title":"Nat Cancer"},{"key":"5648_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13304-4","author":"H Wang","year":"2024","unstructured":"Wang H, Fan M, Liu S, et al. Redox homeostasis of one-carbon metabolism-dependent reprogramming is critical for RCC progression under exogenous serine\/glycine-deprived conditions. BMC Cancer. 2024. https:\/\/doi.org\/10.1186\/s12885-024-13304-4.","journal-title":"BMC Cancer"},{"key":"5648_CR21","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20222553","author":"Y Wang","year":"2023","unstructured":"Wang Y, Huo L, Yang C, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility: an updated meta-analysis. Biosci Rep. 2023. https:\/\/doi.org\/10.1042\/BSR20222553.","journal-title":"Biosci Rep"},{"key":"5648_CR22","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2024.11.05","author":"K Arjmandi","year":"2025","unstructured":"Arjmandi K, Salahshourifar I, Irani S, et al. Association study of TYMS gene expression with TYMS and ENOSF1 genetic variants in neoadjuvant chemotherapy response of gastric cancer. J Pathol Transl Med. 2025. https:\/\/doi.org\/10.4132\/jptm.2024.11.05.","journal-title":"J Pathol Transl Med"},{"key":"5648_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00926-5","author":"H Deng","year":"2025","unstructured":"Deng H, Wang Y, Xiao L, et al. SHMT inhibitor synergizes with 5-Fu to suppress gastric cancer via cell cycle arrest and chemoresistance alleviation. NPJ Precis Oncol. 2025. https:\/\/doi.org\/10.1038\/s41698-025-00926-5.","journal-title":"NPJ Precis Oncol"},{"key":"5648_CR24","doi-asserted-by":"publisher","DOI":"10.2174\/0113892029382696251125102036","author":"G Yang","year":"2025","unstructured":"Yang G, Yu J, Deng X, et al. Unveiling the role of sialylation-related lncRNAs in lung adenocarcinoma: a new prognostic model. Curr Genomics. 2025. https:\/\/doi.org\/10.2174\/0113892029382696251125102036.","journal-title":"Curr Genomics"},{"key":"5648_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1770711","author":"Y Wang","year":"2026","unstructured":"Wang Y, Zhang Y, Li Y, et al. The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification. Front Immunol. 2026. https:\/\/doi.org\/10.3389\/fimmu.2026.1770711.","journal-title":"Front Immunol"},{"key":"5648_CR26","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S553681","author":"Y Gou","year":"2025","unstructured":"Gou Y, Li Y, Wang Y, et al. Integrated pan-cancer profiling and breast cancer validation identify BEND3 as a potential prognostic and immune biomarker. Breast Cancer Targets Ther. 2025. https:\/\/doi.org\/10.2147\/BCTT.S553681.","journal-title":"Breast Cancer Targets Ther"},{"key":"5648_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1667589","author":"J Wang","year":"2025","unstructured":"Wang J, Wang Y, Ma H, et al. CLIC6\u2019s role in cancer: from broad analysis to breast cancer validation. Front Oncol. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1667589.","journal-title":"Front Oncol"},{"key":"5648_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1670526","author":"D Elihamu","year":"2025","unstructured":"Elihamu D, Li Y, Wang Y, et al. CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation. Front Oncol. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1670526.","journal-title":"Front Oncol"},{"key":"5648_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08536-7","author":"S Wang","year":"2021","unstructured":"Wang S, Pang L, Liu Z, et al. SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target. BMC Cancer. 2021. https:\/\/doi.org\/10.1186\/s12885-021-08536-7.","journal-title":"BMC Cancer"},{"key":"5648_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10050-6","author":"Z Yang","year":"2025","unstructured":"Yang Z, Zhong D, Hu X, et al. NFATC2\/SERPINE1\/JAK3\/STAT3 signaling feedback loop in gastric cancer: immune evasion and anti-PD-1 resistance. Cell Biol Toxicol. 2025. https:\/\/doi.org\/10.1007\/s10565-025-10050-6.","journal-title":"Cell Biol Toxicol"},{"key":"5648_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28234-7","author":"Y Zhai","year":"2023","unstructured":"Zhai Y, Liu X, Huang Z, et al. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma. Sci Rep. 2023. https:\/\/doi.org\/10.1038\/s41598-023-28234-7.","journal-title":"Sci Rep"},{"key":"5648_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-9-14","author":"MM Hussain","year":"2012","unstructured":"Hussain MM, Rava P, Walsh M, et al. Multiple functions of microsomal triglyceride transfer protein. Nutr Metab. 2012. https:\/\/doi.org\/10.1186\/1743-7075-9-14.","journal-title":"Nutr Metab"},{"key":"5648_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1549965","author":"W Wang","year":"2025","unstructured":"Wang W, Gao Y, Liu Y, et al. Pan-cancer analysis reveals MTTP as a prognostic and immunotherapeutic biomarker in human tumors. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1549965.","journal-title":"Front Immunol"},{"key":"5648_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03900-3","author":"Z Nasseri Moghaddam","year":"2025","unstructured":"Nasseri Moghaddam Z, Reinhardt EK, Thurm A, et al. Establishing a core outcome set for creatine transporter deficiency and guanidinoacetate methyltransferase deficiency. Orphanet J Rare Dis. 2025. https:\/\/doi.org\/10.1186\/s13023-025-03900-3.","journal-title":"Orphanet J Rare Dis"},{"key":"5648_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83580-4","author":"W Wu","year":"2025","unstructured":"Wu W, Tao G, Chen Z, et al. Identification of disulfidptosis-related subtypes in gastric cancer and GAMT is a key gene during disulfidptosis. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-024-83580-4.","journal-title":"Sci Rep"},{"key":"5648_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18257-3","author":"T Tsukiyama","year":"2020","unstructured":"Tsukiyama T, Zou J, Kim J, et al. A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-18257-3.","journal-title":"Nat Commun"},{"key":"5648_CR37","volume-title":"Phase-specific dynamics of coagulation factors V, VIII, and XIII during liver transplantation: insights from a prospective study","author":"S Thaler","year":"2026","unstructured":"Thaler S, Zorn A, Aster I, et al. Phase-specific dynamics of coagulation factors V, VIII, and XIII during liver transplantation: insights from a prospective study. London, England: Perioperative medicine; 2026."},{"key":"5648_CR38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0290","author":"KG Mann","year":"2003","unstructured":"Mann KG, Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood. 2003. https:\/\/doi.org\/10.1182\/blood-2002-01-0290.","journal-title":"Blood"},{"key":"5648_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9280841","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liao XW, Qin YZ, et al. Identification of F5 as a prognostic biomarker in patients with gastric cancer. BioMed Res Int. 2020. https:\/\/doi.org\/10.1155\/2020\/9280841.","journal-title":"BioMed Res Int"},{"key":"5648_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146600","author":"L Gao","year":"2025","unstructured":"Gao L, Han Q, Ma C, et al. Multi-omic analysis reveals the role of coagulation factor family genes and their predictive value for immune checkpoint inhibitors efficacy in gastric cancer. Int J Biol Macromol. 2025. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146600.","journal-title":"Int J Biol Macromol"},{"key":"5648_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02005-w","author":"S Chen","year":"2024","unstructured":"Chen S, Zhu H, Jounaidi Y. Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-02005-w.","journal-title":"Signal Transduct Target Ther"},{"key":"5648_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08254-z","author":"S Yang","year":"2025","unstructured":"Yang S, Yang Y, Fang Y, et al. Targeting tumour-infiltrating B cells: mechanisms and advances in cancer therapy. Cell Death Dis. 2025. https:\/\/doi.org\/10.1038\/s41419-025-08254-z.","journal-title":"Cell Death Dis"},{"key":"5648_CR43","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-24-0320","author":"FM Cruz","year":"2025","unstructured":"Cruz FM, Orellano LAA, Chan A, et al. Alternate MHC I antigen presentation pathways allow CD8+ T-cell recognition and killing of cancer cells in the absence of \u03b22M or TAP. Cancer Immunol Res. 2025. https:\/\/doi.org\/10.1158\/2326-6066.CIR-24-0320.","journal-title":"Cancer Immunol Res"},{"key":"5648_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B, et al. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01979-x.","journal-title":"Signal Transduct Target Ther"},{"key":"5648_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02242-7","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Shen G, Zhou X, et al. Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity. Signal Transduct Target Ther. 2025. https:\/\/doi.org\/10.1038\/s41392-025-02242-7.","journal-title":"Signal Transduct Target Ther"},{"key":"5648_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131673","author":"X Chen","year":"2023","unstructured":"Chen X, Li Y, Xia H, et al. Monocytes in tumorigenesis and tumor immunotherapy. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12131673.","journal-title":"Cells"},{"key":"5648_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1678907","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu K, Xu Y, et al. Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1678907.","journal-title":"Front Immunol"},{"key":"5648_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/sci\/1325262","author":"P Wang","year":"2025","unstructured":"Wang P, Xu S, Guo Q, et al. Discovery of PAK2 as a key regulator of cancer stem cell in head and neck squamous cell carcinoma using multi-omic techniques. Stem Cells Int. 2025. https:\/\/doi.org\/10.1155\/sci\/1325262.","journal-title":"Stem Cells Int"},{"key":"5648_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.05.010","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Xie E, Xu H, et al. One-carbon metabolism shapes T cell immunity in cancer. Trends Endocrinol Metab. 2024. https:\/\/doi.org\/10.1016\/j.tem.2024.05.010.","journal-title":"Trends Endocrinol Metab"},{"key":"5648_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1354735","author":"F Zhang","year":"2024","unstructured":"Zhang F, Huang B, Utturkar SM, et al. Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1354735.","journal-title":"Front Immunol"},{"key":"5648_CR51","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1414","author":"GM Cresswell","year":"2021","unstructured":"Cresswell GM, Wang B, Kischuk EM, et al. Folate receptor beta designates immunosuppressive tumor-associated myeloid cells that can be reprogrammed with folate-targeted drugs. Cancer Res. 2021. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1414.","journal-title":"Cancer Res"},{"key":"5648_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-025-00342-6","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhou T, Zheng Y, et al. Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer. Genes Immun. 2025. https:\/\/doi.org\/10.1038\/s41435-025-00342-6.","journal-title":"Genes Immun"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05648-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05648-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05648-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:19:50Z","timestamp":1785518390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05648-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5648"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05648-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1082"}}